Will Big Pharma Embrace Its Orphans?

Will Big Pharma Embrace Its Orphans?

LONDON, November 17 /PRNewswire/ -- While most big pharmaceutical and biotechnology companies have traditionally depended on blockbuster molecules, it is estimated that $90.0 billion worth of…